0001701259-21-000001.txt : 20210520
0001701259-21-000001.hdr.sgml : 20210520
20210520132913
ACCESSION NUMBER: 0001701259-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210520
DATE AS OF CHANGE: 20210520
EFFECTIVENESS DATE: 20210520
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptive Phage Therapeutics, Inc.
CENTRAL INDEX KEY: 0001701259
IRS NUMBER: 814208730
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-400058
FILM NUMBER: 21943756
BUSINESS ADDRESS:
STREET 1: 22 FIRSTFIELD ROAD
STREET 2: SUITE 125
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 2408992532
MAIL ADDRESS:
STREET 1: 22 FIRSTFIELD ROAD
STREET 2: SUITE 125
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
D
1
primary_doc.xml
X0708
D
LIVE
0001701259
Adaptive Phage Therapeutics, Inc.
708 Quince Orchard Rd
Suite 205
GAITHERSBURG
MD
MARYLAND
20878
844-972-0500
DELAWARE
None
None
Corporation
true
2017
Gregory
L.
Merril
c/o Adaptive Phage Therapeutics, Inc.
708 Quince Orchard Rd., Suite 205
Gaithersburg
MD
MARYLAND
20878
Executive Officer
Director
Promoter
Carl
R.
Merril
c/o Adaptive Phage Therapeutics, Inc.
708 Quince Orchard Rd., Suite 205
Gaithersburg
MD
MARYLAND
20878
Executive Officer
Director
Raymond
L.
Martz
c/o Adaptive Phage Therapeutics, Inc.
708 Quince Orchard Rd., Suite 205
Gaithersburg
MD
MARYLAND
20878
Director
Jonathan
Leff
c/o Adaptive Phage Therapeutics, Inc.
708 Quince Orchard Rd., Suite 205
Gaithersburg
MD
MARYLAND
20878
Director
Jana
Jensen
c/o Adaptive Phage Therapeutics, Inc.
708 Quince Orchard Rd., Suite 205
Gaithersburg
MD
MARYLAND
20878
Director
Evan
Loh
c/o Adaptive Phage Therapeutics, Inc.
708 Quince Orchard Rd., Suite 205
Gaithersburg
MD
MARYLAND
20878
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-05-07
false
true
false
0
53262037
23262000
30000037
The amount sold includes the convertible debt issued in exchange for equity.
false
59
0
0
0
false
Adaptive Phage Therapeutics, Inc.
/s/ Gregory L. Merril
Gregory L. Merril
Chief Executive Officer
2021-05-20